← Leaderboards
Bradford S Schwartz
University Of Illinois Urbana-Champaign
$25,961
Attributed
$27,254
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10K · FY2005–12$10K$7.5K$5K$2.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$27,254 · 4
By mechanism
R13$20,000 · 2
P41$4,667 · 1
K12$2,587 · 1
Top collaborators
- Gloria Elizabeth Sarto1 shared
Most similar at University Of Illinois Urbana-Champaign
Same institution · by research overlap
- Martha U Gillette$8,924,747
- Shih-Hon Li$174,766
- Valeria Caiolfa$241,258
- Richard Ian Tapping$5,224,459
- Kelly A Tappenden$1,260,328
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelScientistWomanFrontierAreaInternationalInnovationLeadHematopoiesisGraduate StudentBlood VesselsAchievementBasic ScienceCardiovascular SystemHomeostasisClinical ResearchAlteplaseFunctional DisorderExtracellularCollaborationsDeep Vein ThrombosisBiologyDisciplineAngiogenesis
Grant awards (5)
BUILDING INTERDISCIPLINARY RESEARCH CAREER IN WOMEN'S HEALTH (BIRCWH) SCHOLARS$2,587
K12 · FY2012 · HD
2012 Gordon Research Conference and Gordon-Kenan Research Seminar on Plasminogen$10,000
R13 · FY2011 · HL · contact PI
2010 Gordon Research Conference on Plasminogen Activation and Ertracellular Prote$10,000
R13 · FY2010 · HL · contact PI
TRITON X-100 AFFECTS THE INHIBITION OF T-PA AND U-PA BY PAI-1 DIFFERENTLY$3,859
P41 · FY2005 · RR
TRITON X-100 AFFECTS THE INHIBITION OF T-PA AND U-PA BY PAI-1 DIFFERENTLY$808
P41 · FY2004 · RR